228 related articles for article (PubMed ID: 36998446)
1. Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma.
Di Giorgio C; Bellini R; Lupia A; Massa C; Bordoni M; Marchianò S; Rosselli R; Sepe V; Rapacciuolo P; Moraca F; Morretta E; Ricci P; Urbani G; Monti MC; Biagioli M; Distrutti E; Catalanotti B; Zampella A; Fiorucci S
Front Oncol; 2023; 13():1140730. PubMed ID: 36998446
[TBL] [Abstract][Full Text] [Related]
2. Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma.
Di Giorgio C; Lupia A; Marchianò S; Bordoni M; Bellini R; Massa C; Urbani G; Roselli R; Moraca F; Sepe V; Catalanotti B; Morretta E; Monti MC; Biagioli M; Distrutti E; Zampella A; Fiorucci S
Cells; 2022 Nov; 11(21):. PubMed ID: 36359879
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome Analysis of Dual FXR and GPBAR1 Agonism in Rodent Model of NASH Reveals Modulation of Lipid Droplets Formation.
Carino A; Marchianò S; Biagioli M; Fiorucci C; Zampella A; Monti MC; Morretta E; Bordoni M; Di Giorgio C; Roselli R; Ricci P; Distrutti E; Fiorucci S
Nutrients; 2019 May; 11(5):. PubMed ID: 31117231
[TBL] [Abstract][Full Text] [Related]
4. Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis.
Di Giorgio C; Morretta E; Lupia A; Bellini R; Massa C; Urbani G; Bordoni M; Marchianò S; Lachi G; Rapacciuolo P; Finamore C; Sepe V; Chiara Monti M; Moraca F; Natalizi N; Graziosi L; Distrutti E; Biagioli M; Catalanotti B; Donini A; Zampella A; Fiorucci S
Biochem Pharmacol; 2024 May; 223():116134. PubMed ID: 38494064
[TBL] [Abstract][Full Text] [Related]
5. Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis.
Di Giorgio C; Marchianò S; Marino E; Biagioli M; Roselli R; Bordoni M; Bellini R; Urbani G; Zampella A; Distrutti E; Donini A; Graziosi L; Fiorucci S
Front Oncol; 2022; 12():939969. PubMed ID: 35847866
[TBL] [Abstract][Full Text] [Related]
6. Evidence for heterodimeric association of leukemia inhibitory factor (LIF) receptor and gp130 in the mouse uterus for LIF signaling during blastocyst implantation.
Song H; Lim H
Reproduction; 2006 Feb; 131(2):341-9. PubMed ID: 16452727
[TBL] [Abstract][Full Text] [Related]
7. Targeting LIF/LIFR signaling in cancer.
Viswanadhapalli S; Dileep KV; Zhang KYJ; Nair HB; Vadlamudi RK
Genes Dis; 2022 Jul; 9(4):973-980. PubMed ID: 35685476
[TBL] [Abstract][Full Text] [Related]
8. Activation of cytokine signaling through leukemia inhibitory factor receptor (LIFR)/gp130 attenuates ischemic brain injury in rats.
Suzuki S; Yamashita T; Tanaka K; Hattori H; Sawamoto K; Okano H; Suzuki N
J Cereb Blood Flow Metab; 2005 Jun; 25(6):685-93. PubMed ID: 15716858
[TBL] [Abstract][Full Text] [Related]
9. Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH.
Marchianò S; Biagioli M; Morretta E; Di Giorgio C; Roselli R; Bordoni M; Bellini R; Urbani G; Massa C; Monti MC; Zampella A; Distrutti E; Fiorucci S
Sci Rep; 2023 Jan; 13(1):1602. PubMed ID: 36709356
[TBL] [Abstract][Full Text] [Related]
10. Affinity maturation of leukemia inhibitory factor and conversion to potent antagonists of signaling.
Fairlie WD; Uboldi AD; McCoubrie JE; Wang CC; Lee EF; Yao S; De Souza DP; Mifsud S; Metcalf D; Nicola NA; Norton RS; Baca M
J Biol Chem; 2004 Jan; 279(3):2125-34. PubMed ID: 14585833
[TBL] [Abstract][Full Text] [Related]
11. Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor.
Plun-Favreau H; Perret D; Diveu C; Froger J; Chevalier S; Lelièvre E; Gascan H; Chabbert M
J Biol Chem; 2003 Jul; 278(29):27169-79. PubMed ID: 12707269
[TBL] [Abstract][Full Text] [Related]
12. Regulation of neurokine receptor signaling and trafficking.
Nathanson NM
Neurochem Int; 2012 Nov; 61(6):874-8. PubMed ID: 22306348
[TBL] [Abstract][Full Text] [Related]
13. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
[TBL] [Abstract][Full Text] [Related]
14. Nanoluciferase as a novel quantitative protein fusion tag: Application for overexpression and bioluminescent receptor-binding assays of human leukemia inhibitory factor.
He SX; Song G; Shi JP; Guo YQ; Guo ZY
Biochimie; 2014 Nov; 106():140-8. PubMed ID: 25179300
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of leukemia inhibitory factor (LIF), LIFR, gp130, and IL11 in the embryo implantation site of rat model with prenatal androgen-induced polycystic ovary syndrome.
Javidan M; Changaei M; Ramezani Tehrani F; Mosaffa N; Noroozzadeh M; Hosseinzadeh R; Rajaei S
Biochem Biophys Res Commun; 2022 May; 605():24-30. PubMed ID: 35306361
[TBL] [Abstract][Full Text] [Related]
16. The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex.
Aasland D; Oppmann B; Grötzinger J; Rose-John S; Kallen KJ
J Mol Biol; 2002 Jan; 315(4):637-46. PubMed ID: 11812136
[TBL] [Abstract][Full Text] [Related]
17. BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis.
Carino A; Cipriani S; Marchianò S; Biagioli M; Santorelli C; Donini A; Zampella A; Monti MC; Fiorucci S
Sci Rep; 2017 Feb; 7():42801. PubMed ID: 28202906
[TBL] [Abstract][Full Text] [Related]
18. A functional role of the membrane-proximal extracellular domains of the signal transducer gp130 in heterodimerization with the leukemia inhibitory factor receptor.
Timmermann A; Küster A; Kurth I; Heinrich PC; Müller-Newen G
Eur J Biochem; 2002 Jun; 269(11):2716-26. PubMed ID: 12047380
[TBL] [Abstract][Full Text] [Related]
19. LIF receptor-gp130 interaction investigated by homology modeling: implications for LIF binding.
Smith DK; Treutlein HR
Protein Sci; 1998 Apr; 7(4):886-96. PubMed ID: 9568895
[TBL] [Abstract][Full Text] [Related]
20. Mutant KRAS Downregulates the Receptor for Leukemia Inhibitory Factor (LIF) to Enhance a Signature of Glycolysis in Pancreatic Cancer and Lung Cancer.
Liu S; Gandler HI; Tošić I; Ye DQ; Giaccone ZT; Frank DA
Mol Cancer Res; 2021 Aug; 19(8):1283-1295. PubMed ID: 33931487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
